In 2020, market access rebates and discounts as a subcomponent of gross expenditures for brand medicines accounted for more than 102 billion U.S. dollars in the United States. The statistic illustrates the total market access rebates and discounts for brand medicines by components from 2013 to 2020, by component.
Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component
(in billion U.S. dollars)
Characteristic
Negotiated health plan and PBM rebates and fees
Patient cost sharing assistance
2020
102.1
13.9
2019
93.1
12.9
2018
81.9
12.9
2017
67.4
10.6
2016
59
8.7
2015
54.9
6.9
2014
42.1
5.4
2013
31.2
4.2
0255075100125
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Statista has been my savior on several occasions.
The site is easy to maneuver and the data is in a format that can
go right into a report or presentation.
Learn more about how Statista can support your business.
BRG. (January 31, 2022). Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) [Graph]. In Statista. Retrieved March 01, 2025, from https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. "Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)." Chart. January 31, 2022. Statista. Accessed March 01, 2025. https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. (2022). Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars). Statista. Statista Inc.. Accessed: March 01, 2025. https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. "Market Access Rebates and Discounts for Brand Medicines in The U.S. from 2013 to 2020, by Component (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Jan 2022, https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG, Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/ (last visited March 01, 2025)
Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) [Graph], BRG, January 31, 2022. [Online]. Available: https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
